In this golden Autumn, good news keeps pouring in. In the National Mass Innovation and Grassroot Entrepreneurship Week Campaign held by Beijing Economic and Technological Development Area (BDA), Beijing Health Guard Biotechnology, Inc. (thereafter, the Company) won the BDA’s 2020 High-Value Patent Innovation Award (the First Session) with its patent “Recombinant HPV 16-L1 and its Uses”.
Contestants for this award include many firms that excel in their respective fields. Therefore, it is a great honor for the Company to claim such an award after multiple rounds of appraisal, which not only represents a recognition of the Company’s innovation prowess, but also incentivizes the patent owners who’ve made remarkable contributions.
The Company has always attached great importance to the protection of intellectual property rights. Since the inception of the Company, we have filed 25 patent applications, 14 of which have been granted patent rights. Moreover, the Company has been selected as a “Beijing Patent Engine Pilot Firm”. As a biotech committed to the development of advanced and innovative vaccines, the Company will continue to power ahead and indomitably blaze its way forward through all difficulties on the journey of innovation.